Literature DB >> 31873749

Statins as Adjunctive Therapy Against Tuberculosis (TB): The Balance Between Statin-Induced Anti-TB Effect and Trained Immunity Suppression.

Zhidong Hu1, Douglas B Lowrie1, Xiao-Yong Fan1.   

Abstract

Entities:  

Year:  2020        PMID： 31873749     DOI： 10.1093/infdis/jiz675

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

Review 1.  Further insights into to the role of statins against active tuberculosis: systematic review and meta-analysis.

Authors:  Edinson Dante Meregildo-Rodriguez; Eleodoro Vladimir Chunga-Chévez; Robles-Arce Luis Gianmarco; Gustavo Adolfo Vásquez-Tirado
Journal:  Infez Med       Date:  2022-06-01

2.  Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 7.759

Review 3.  The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review.

Authors:  Chiyun Lee; Sanjib Bhakta
Journal:  Antibiotics (Basel)       Date:  2021-01-19

Review 4.  Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology.

Authors:  Caleb N Muefong; Jayne S Sutherland
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

5.  Platelets mediate trained immunity against bone and joint infections in a mouse model.

Authors:  Tao Gao; Junqing Lin; Haifeng Wei; Bingbo Bao; Hongyi Zhu; Xianyou Zheng
Journal:  Bone Joint Res       Date:  2022-02       Impact factor: 5.853
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.